Tag: Polyp Biopsy Market Share

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The polyp biopsy market has demonstrated impressive growth in recent years and continues to show promising potential for expansion. Driven by advancements in technology and rising disease prevalence, this sector is set to experience notable revenue increases over the forecast period. Let’s explore the current market size, key growth drivers, emerging trends, major players, and regional dynamics shaping this industry.

Polyp Biopsy Market Size and Projected Growth Through 2030

The market for polyp biopsy has witnessed substantial growth and is projected to increase from $1.39 billion in 2025 to $1.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This upward trend in recent years is linked to the rising incidence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, expanded screening programs, greater awareness about early diagnosis, and the growth of specialty clinics. Looking ahead, the market is expected to grow robustly, reaching $2.06 billion by 2030 at a CAGR of 8.2%. Key factors propelling this expansion include the adoption of AI-assisted biopsy procedures, minimally invasive techniques, wider use in hospitals and diagnostic labs, integration with imaging and cloud technologies, and the development of innovative biopsy tools. Leading market segments during this period include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (EMR).

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

Factors Fueling Demand Growth in the Polyp Biopsy Market

One of the primary drivers of the polyp biopsy market is the increasing prevalence of colorectal cancer worldwide. This cancer originates in the colon or rectum due to abnormal proliferation of epithelial cells lining the large intestine, with the potential to invade surrounding tissues and metastasize. The rise in colorectal cancer cases is largely influenced by dietary habits high in processed foods and low fiber content, which promote chronic inflammation and disrupt gut microbiota, fostering the development of precancerous lesions. Polyp biopsy plays a crucial role in early detection and histopathological examination of suspicious lesions, thereby facilitating timely intervention and preventing disease progression.

To illustrate the impact, the American Cancer Society (ACS) estimates that in 2025, there will be approximately 107,320 new colon cancer cases and 46,950 rectal cancer diagnoses in the United States, with nearly 52,900 deaths attributed to these conditions. This significant disease burden underscores the vital need for improved diagnostic tools, which in turn is accelerating demand within the polyp biopsy market.

Access The Complete Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Product and Application Segments Defining the Polyp Biopsy Market

The polyp biopsy market is categorized across several important segments for precise market analysis:

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Furthermore, subcategories deepen the segmentation: Colonoscopy is divided into diagnostic and therapeutic types; Colposcopy-Directed Biopsy includes cervical, vaginal, and vulvar biopsies; Esophagogastroduodenoscopy is split into diagnostic and therapeutic procedures.

Innovations and Trends Advancing the Polyp Biopsy Market

Key players in this market are heavily investing in innovative technologies such as AI-assisted detection systems, which enhance the identification of colorectal polyps and facilitate early cancer detection. These AI systems analyze medical imaging in real time, flagging abnormalities to assist clinicians in making informed decisions without conducting therapeutic procedures during detection.

For example, in September 2024, Odin Medical Ltd., a US medical technology firm affiliated with Olympus Corporation, introduced CADDIE—a cloud-based AI endoscopic platform. This solution processes colonoscopy video feeds in real time to highlight potential colorectal polyps, enabling endoscopists to improve adenoma detection rates. Clinical trials have demonstrated that CADDIE enhances diagnostic accuracy without extending procedure times or increasing risks, highlighting its potential to transform patient care and outcomes.

Key Industry Players Influencing the Polyp Biopsy Market

The competitive landscape of the polyp biopsy market includes prominent corporations such as Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., and Innovia Medical. These companies are at the forefront of driving innovation and expanding market reach.

Regional Market Dynamics and Growth Outlook

In 2025, North America held the largest share of the polyp biopsy market, owing to advanced healthcare infrastructure and high disease awareness. However, the Asia-Pacific region is predicted to be the fastest-growing market throughout the forecast period, driven by rising healthcare investments and increasing prevalence of gastrointestinal cancers. The comprehensive geographic analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Polyp Biopsy Market Projected To Reach By 2030?

The polyp biopsy market has experienced robust expansion recently. This market is projected to expand from $1.39 billion in 2025 to $1.5 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion has been driven by factors such as an increasing incidence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the proliferation of screening initiatives, greater understanding of the advantages of early diagnosis, and the establishment of more specialty clinics.

The polyp biopsy market is anticipated to experience substantial expansion over the coming years. By 2030, its value is projected to reach $2.06 billion, demonstrating a compound annual growth rate (CAGR) of 8.2%. This increase during the forecast period is primarily fueled by factors such as AI-assisted biopsy procedures, the adoption of minimally invasive techniques, the broader implementation in hospitals and diagnostic laboratories, integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Key developments expected during this period involve colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (emr).

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

What Key Factors Are Affecting The Polyp Biopsy Market Demand?

The rising incidence of colorectal cancer is anticipated to fuel the expansion of the polyp biopsy market in the future. Colorectal cancer, a malignant condition, develops in the colon or rectum due to the abnormal, unregulated proliferation of epithelial cells within the large intestine, and is known for its ability to invade adjacent tissues and spread to other organs. This escalating prevalence of colorectal cancer largely stems from prevalent dietary habits rich in processed items and deficient in fiber, factors that foster persistent inflammation, disrupt gut flora, and encourage the formation of precancerous growths that may eventually become malignant. Polyp biopsy serves to lessen the effect of the increasing colorectal cancer prevalence by facilitating the early identification and microscopic assessment of questionable lesions, thus aiding in prompt treatment and hindering the disease’s advancement. For example, the American Cancer Society (ACS), a US-based non-profit organization, forecasts that in 2025, approximately 107,320 new colon cancer cases and 46,950 rectal cancer cases are anticipated to be diagnosed in the United States, with around 52,900 deaths projected from these specific cancers. Consequently, the rising prevalence of colorectal cancer is propelling the growth of the polyp biopsy market.

Which Segment Classifications Are Used In The Polyp Biopsy Market Segment Analysis?

The polyp biopsy market covered in this report is segmented –

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

What Trends Are Influencing Changes In The Polyp Biopsy Market?

Leading companies within the polyp biopsy market are prioritizing the development of cutting-edge innovations, such as AI-assisted detection systems, with the goal of improving the identification of colorectal polyps and facilitating the prompt discovery of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging instantaneously, pinpointing possible abnormalities and issuing visual notifications to clinicians, thereby supporting clinical decision-making without necessitating therapeutic interventions. For instance, in September 2024, Odin Medical Ltd., a US-based medical technology company affiliated with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. The CADDIE device utilizes cloud-based artificial intelligence to analyze colonoscopy video in real time and highlight regions where colorectal polyps are suspected, empowering endoscopists to make well-informed choices during procedures. Clinical trials have shown that the system enhances the adenoma detection rate without prolonging procedural time or increasing associated risks, thereby highlighting its capacity to advance early detection and patient care.

Which Firms Are Contributing To The Polyp Biopsy Market Ecosystem?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Get The Full Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Where Is The Polyp Biopsy Market Primarily Concentrated By Region?

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Polyp Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2026, By The Business Research Company

Kidney Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Polyp Biopsy Market Over The Period 2026–2030?

The polyp biopsy market size has demonstrated strong growth in recent years. It is anticipated to increase from $1.39 billion in 2025 to $1.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The expansion observed historically stems from a confluence of factors, including the rising prevalence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the proliferation of screening programs, heightened awareness regarding the benefits of early diagnosis, and the establishment of specialty clinics.

The polyp biopsy market size anticipates robust expansion in the coming years. This market is projected to reach $2.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period is fueled by factors such as AI-assisted biopsy procedures, the adoption of minimally invasive techniques, the increasing embrace by hospitals and diagnostic laboratories, seamless integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Key trends influencing the forecast period encompass colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (EMR).

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

What Drivers Are Expected To Influence The Polyp Biopsy Market During The Forecast Period?

The escalating occurrence of colorectal cancer is anticipated to drive the expansion of the polyp biopsy market. Colorectal cancer, a malignant disease that emerges in the colon or rectum due to the abnormal, uncontrolled proliferation of epithelial cells lining the large intestine, has the capacity to invade nearby tissues and spread to distant organs. The increasing prevalence of this cancer is primarily attributed to prevalent dietary habits characterized by high consumption of processed foods and insufficient fiber, which foster chronic inflammation, modify the gut microbiota, and facilitate the development of precancerous lesions that can advance to malignancy over time. Polyp biopsy plays a vital role in mitigating the impact of rising colorectal cancer by enabling the early detection and histopathological assessment of suspicious lesions, thereby supporting timely intervention and preventing the disease from progressing. For example, the American Cancer Society (ACS), a US-based non-profit organization, projects that in 2025, approximately 107,320 new cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the United States, with an estimated 52,900 deaths resulting from these cancers. Consequently, the growing prevalence of colorectal cancer is a significant factor propelling the growth of the polyp biopsy market.

How Is The Polyp Biopsy Market Divided Into Its Major Segments?

The polyp biopsy market covered in this report is segmented –

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

How Are Trends Transforming The Polyp Biopsy Market Landscape?

Leading firms within the polyp biopsy market are concentrating on developing advanced innovations, such as AI-driven detection technologies, to improve the identification of colorectal polyps and facilitate the prompt discovery of potential cancerous lesions. An AI-driven detection system functions by analyzing medical images in real-time to spot possible anomalies and alert clinicians visually, thereby assisting clinical decision-making without requiring therapeutic procedures. For instance, in September 2024, Odin Medical Ltd., a US-based medical technology company associated with Olympus Corporation, introduced CADDIE, its cloud-powered AI endoscopic system. The CADDIE device utilizes cloud-based artificial intelligence to process colonoscopy video footage instantly, highlighting regions where colorectal polyps are suspected, which empowers endoscopists to make well-informed choices during interventions. Clinical studies demonstrated that this system enhances the adenoma detection rate without extending procedural duration or risk, emphasizing its capacity to improve early diagnosis and patient outcomes.

Who Are The Prominent Organizations Shaping The Polyp Biopsy Market?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Read the full polyp biopsy market report here:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Which Region Is Forecast To Lead The Polyp Biopsy Market In Terms Of Market Size?

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Polyp Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28304&type=smp

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2026, By The Business Research Company

Kidney Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Polyp Biopsy Market from 2026 to 2030?

The polyp biopsy market has shown robust expansion in recent years. It is forecast to increase from $1.39 billion in 2025 to $1.5 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. The market’s past growth can be ascribed to the increasing incidence of gastrointestinal and cervical cancers, enhancements in endoscopic technologies, the expansion of screening programs, improved awareness regarding the benefits of early diagnosis, and the development of specialty clinics.

The polyp biopsy market size is projected to experience substantial expansion in the coming years. This market is predicted to reach $2.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. Key factors driving this growth over the forecast period include the increasing adoption of AI-assisted biopsy procedures, advancements in minimally invasive techniques, wider integration into hospital and diagnostic laboratory settings, incorporation with imaging and cloud platforms, and the creation of innovative biopsy instruments. Prominent trends anticipated during this period encompass colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (emr).

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

What Drivers Are Affecting Demand In The Polyp Biopsy Market?

The rising incidence of colorectal cancer is anticipated to drive the expansion of the polyp biopsy market in the coming years. Colorectal cancer, a malignant condition, originates in the colon or rectum due to the uncontrolled proliferation of epithelial cells lining the large intestine, known for its capacity to invade adjacent tissues and spread to remote organs. The growing occurrence of colorectal cancer is largely fueled by prevalent dietary habits, particularly those rich in processed foods and deficient in fiber. These patterns foster chronic inflammation, modify gut microbiota, and support the formation of precancerous lesions that may eventually become malignant. Polyp biopsy plays a crucial role in reducing the effects of increasing colorectal cancer prevalence by allowing for the early identification and histopathological assessment of suspicious growths, thus facilitating prompt treatment and hindering the advancement of the disease. For example, the American Cancer Society (ACS), a US-based non-profit organization, forecasts that in 2025, approximately 107,320 new cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the United States, with around 52,900 deaths anticipated from these cancers. Consequently, the expanding prevalence of colorectal cancer is propelling the development of the polyp biopsy market.

Which Segment Groups Are Influencing The Polyp Biopsy Market?

The polyp biopsy market covered in this report is segmented –

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

What Industry Trends Are Transforming The Polyp Biopsy Market?

Leading companies in the polyp biopsy market are prioritizing the development of innovative advancements, such as AI-assisted detection systems, to enhance the identification of colorectal polyps and support the early discovery of potential cancerous lesions. An AI-assisted detection system is a technology that processes medical imaging in real-time to pinpoint potential abnormalities and provide visual alerts to clinicians, thereby aiding clinical decision-making without performing therapeutic interventions. For example, in September 2024, Odin Medical Ltd., a US-based medical technology company associated with Olympus Corporation, launched CADDIE, a cloud-based AI endoscopic system. The CADDIE device employs cloud-based artificial intelligence to analyze colonoscopy video in real-time, highlighting areas with suspected colorectal polyps, which enables endoscopists to make informed decisions during procedures. Clinical trials have demonstrated that this system improves the adenoma detection rate without extending procedural time or increasing risk, underscoring its capacity to enhance early detection and patient care.

Who Are The Prominent Global Companies Shaping The Polyp Biopsy Market Landscape?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Which Region Is Projected To Lead The Polyp Biopsy Market During The Forecast Period?

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Polyp Biopsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28304&type=smp

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2026, By The Business Research Company

Kidney Biopsy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Polyp Biopsy Market?

The polyp biopsy market size has demonstrated robust expansion in recent years. It is anticipated to grow from $1.27 billion in 2024 to $1.39 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.7%. The historical increase can be attributed to heightened awareness of colorectal cancer screening, a rising incidence of gastrointestinal disorders, the development of hospital and diagnostic infrastructure, government-supported screening programs, and advancements in biopsy forceps technology.

The polyp biopsy market is projected to experience substantial expansion over the next few years. It is anticipated to reach $1.91 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.3%. This anticipated growth over the forecast period is propelled by several factors, including an increasing demand for minimally invasive procedures, a surge in the adoption of disposable biopsy devices, greater healthcare investments focused on early cancer detection, broadened insurance coverage for diagnostic processes, and an aging worldwide population boosting screening participation. Key trends during this period are expected to encompass the incorporation of artificial intelligence into biopsy analysis, the emergence of robotic-assisted biopsy techniques, an increased utilization of disposable and single-use devices, a developing preference for outpatient and ambulatory care facilities, and a general move towards personalized medicine and precision diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

Which Drivers Are Shaping The Polyp Biopsy Industry’s Market Share?

The rising incidence of colorectal cancer is anticipated to drive the expansion of the polyp biopsy market in the future. Colorectal cancer, a malignant condition, originates in the colon or rectum. It stems from the abnormal and uncontrolled proliferation of epithelial cells within the large intestine and is known for its capacity to infiltrate nearby tissues and spread to distant organs. The escalating occurrence of colorectal cancer is chiefly fueled by common dietary habits rich in processed foods and deficient in fiber. These habits foster persistent inflammation, modify the gut microbiota, and aid in the formation of precancerous lesions that may advance to malignancy eventually. Polyp biopsy plays a crucial role in lessening the effects of the increasing prevalence of colorectal cancer. It achieves this by allowing for the early discovery and histopathological assessment of potentially problematic lesions, consequently facilitating prompt treatment and hindering the advancement of the disease. As an illustration, for 2025, the American Cancer Society (ACS), a US-based non-profit organization, estimates that 107,320 new cases of colon cancer and 46,950 cases of rectal cancer are anticipated to be diagnosed in the United States, alongside approximately 52,900 fatalities from these specific cancers. Consequently, the expanding prevalence of colorectal cancer is propelling the growth of the polyp biopsy market.

What Are The Different Segment Classifications Within The Polyp Biopsy Market?

The polyp biopsy market covered in this report is segmented as

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy, Laryngoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Distribution Channel: Online Sales Channels, Retail Pharmacies, Other Distribution Channels

4) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Screening Colonoscopy, Therapeutic Colonoscopy, Virtual Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy, Anal Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy, Surveillance Esophagogastroduodenoscopy, Screening Esophagogastroduodenoscopy

4) By Laryngoscopy: Direct Laryngoscopy, Indirect Laryngoscopy, Flexible Laryngoscopy, Rigid Laryngoscopy

Which Trends Are Impacting The Polyp Biopsy Market?

Leading companies active in the polyp biopsy market are concentrating on creating cutting-edge developments, like AI-assisted detection systems, to improve the identification of colorectal polyps and aid in the early discovery of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging in real-time, pinpointing potential abnormalities and issuing visual alerts to clinicians, thereby supporting clinical decision-making without engaging in therapeutic interventions. For example, in September 2024, Odin Medical Ltd., a US-based medical technology company connected with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. This CADDIE device utilizes cloud-based artificial intelligence to analyze colonoscopy video instantaneously and highlight areas where colorectal polyps are suspected, enabling endoscopists to make informed choices during procedures. Clinical trials showed that the system improves the adenoma detection rate without increasing procedural duration or risk, emphasizing its capability to enhance early detection and patient care.

Which Major Firms Are Strengthening Their Position In The Polyp Biopsy Industry?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., Cooper Surgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

How Is Polyp Biopsy Market Demand Varying Across Different Regions?

North America was the largest region in the polyp biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polyp biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28304&type=smp

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2025, By The Business Research Company

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Kidney Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model